BriLife

Summary

BriLife is a funded product^[1]. BriLife draws 7 Wikipedia views per month (funded_product category, ranking #9 of 11).^[2]

Key Facts

• BriLife's image is recorded as Reuven Rivlin with the first vaccinator in Phase B of the Israeli Vaccine of the Israeli Biological Institute, January 2021 (GPOABG 4045).jpg^[3].
• BriLife's instance of is recorded as funded product^[4].
• BriLife's manufacturer is recorded as Israel Institute for Biological Research^[5].
• BriLife's developer is recorded as Israel Institute for Biological Research^[6].
• BriLife's subclass of is recorded as COVID-19 vaccine^[7].
• BriLife's subclass of is recorded as viral vector vaccine^[8].
• BriLife's subclass of is recorded as vaccine candidate^[9].
• BriLife's Commons category is recorded as BriLife^[10].
• BriLife's country of origin is recorded as Israel^[11].
• BriLife's route of administration is recorded as injection^[12].
• BriLife's vaccine for is recorded as COVID-19^[13].
• BriLife's Vaccine Ontology ID is recorded as VO_0005090^[14].
• BriLife's funder is recorded as Israel^[15].

Why It Matters

BriLife draws 7 Wikipedia views per month (funded_product category, ranking #9 of 11).^[2] BriLife has Wikipedia articles in 7 language editions, a strong signal of global cultural recognition.^[16] BriLife is known by 3 alternative names across languages and contexts.^[17]